IL6 and acute respiratory distress syndrome: Treatment with pyridostigmine significantly suppressed plasma IL-1β (Figure 7A), IL-6 (Figure 7B), INF-γ (Figure 7C), TNF (Figure 7D), and IL-10 (Figure 7E) levels in mice with LPS-induced ARDS at 24 h.